Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) EPS (Weighted Average and Diluted): 2009-2024

Historic EPS (Weighted Average and Diluted) for Innoviva (INVA) over the last 14 years, with Dec 2024 value amounting to $0.36.

  • Innoviva's EPS (Weighted Average and Diluted) rose 5300.00% to $1.08 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.13, marking a year-over-year increase of 24.18%. This contributed to the annual value of $0.36 for FY2024, which is 83.64% down from last year.
  • Per Innoviva's latest filing, its EPS (Weighted Average and Diluted) stood at $0.36 for FY2024, which was down 83.64% from $2.20 recorded in FY2023.
  • In the past 5 years, Innoviva's EPS (Weighted Average and Diluted) registered a high of $2.87 during FY2021, and its lowest value of $0.36 during FY2024.
  • Over the past 3 years, Innoviva's median EPS (Weighted Average and Diluted) value was $2.20 (recorded in 2023), while the average stood at $1.64.
  • As far as peak fluctuations go, Innoviva's EPS (Weighted Average and Diluted) soared by 42.08% in 2021, and later crashed by 83.64% in 2024.
  • Innoviva's EPS (Weighted Average and Diluted) (Yearly) stood at $2.02 in 2020, then skyrocketed by 42.08% to $2.87 in 2021, then decreased by 17.42% to $2.37 in 2022, then fell by 7.17% to $2.20 in 2023, then plummeted by 83.64% to $0.36 in 2024.